MEDEOT, Marta
MEDEOT, Marta
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy
2015-01-01 Tiribelli, Mario; Binotto, Gianni; Calistri, Elisabetta; Maino, Elena; Scaffidi, Luigi; Medeot, Marta; Nabergoj, Mitja; Ambrosetti, Achille; Semenzato, Gianpietro; Fanin, Renato; Bonifacio, Massimiliano
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
2020-01-01 Beelen, D. W.; Trenschel, R.; Stelljes, M.; Groth, C.; Masszi, T.; Remenyi, P.; Wagner-Drouet, E. -M.; Hauptrock, B.; Dreger, P.; Luft, T.; Bethge, W.; Vogel, W.; Ciceri, F.; Peccatori, J.; Stolzel, F.; Schetelig, J.; Junghanss, C.; Grosse-Thie, C.; Michallet, M.; Labussiere-Wallet, H.; Schaefer-Eckart, K.; Dressler, S.; Grigoleit, G. U.; Mielke, S.; Scheid, C.; Holtick, U.; Patriarca, F.; Medeot, M.; Rambaldi, A.; Mico, M. C.; Niederwieser, D.; Franke, G. -N.; Hilgendorf, I.; Winkelmann, N. R.; Russo, D.; Socie, G.; Peffault de Latour, R.; Holler, E.; Wolff, D.; Glass, B.; Casper, J.; Wulf, G.; Menzel, H.; Basara, N.; Bieniaszewska, M.; Stuhler, G.; Verbeek, M.; Grass, S.; Iori, A. P.; Finke, J.; Benedetti, F.; Pichlmeier, U.; Hemmelmann, C.; Tribanek, M.; Klein, A.; Mylius, H. A.; Baumgart, J.; Dzierzak-Mietla, M.; Markiewicz, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy | 1-gen-2015 | Tiribelli, Mario; Binotto, Gianni; Calistri, Elisabetta; Maino, Elena; Scaffidi, Luigi; Medeot, Marta; Nabergoj, Mitja; Ambrosetti, Achille; Semenzato, Gianpietro; Fanin, Renato; Bonifacio, Massimiliano | |
| Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial | 1-gen-2020 | Beelen, D. W.; Trenschel, R.; Stelljes, M.; Groth, C.; Masszi, T.; Remenyi, P.; Wagner-Drouet, E. -M.; Hauptrock, B.; Dreger, P.; Luft, T.; Bethge, W.; Vogel, W.; Ciceri, F.; Peccatori, J.; Stolzel, F.; Schetelig, J.; Junghanss, C.; Grosse-Thie, C.; Michallet, M.; Labussiere-Wallet, H.; Schaefer-Eckart, K.; Dressler, S.; Grigoleit, G. U.; Mielke, S.; Scheid, C.; Holtick, U.; Patriarca, F.; Medeot, M.; Rambaldi, A.; Mico, M. C.; Niederwieser, D.; Franke, G. -N.; Hilgendorf, I.; Winkelmann, N. R.; Russo, D.; Socie, G.; Peffault de Latour, R.; Holler, E.; Wolff, D.; Glass, B.; Casper, J.; Wulf, G.; Menzel, H.; Basara, N.; Bieniaszewska, M.; Stuhler, G.; Verbeek, M.; Grass, S.; Iori, A. P.; Finke, J.; Benedetti, F.; Pichlmeier, U.; Hemmelmann, C.; Tribanek, M.; Klein, A.; Mylius, H. A.; Baumgart, J.; Dzierzak-Mietla, M.; Markiewicz, M. |